Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Thoracic 1 CNS 1

Conditions

Brain Neoplasms 12 Glioblastoma 11 Glioma 6 Neoplasm Metastasis 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Oligodendroglioma 3 Meningioma 3 Gliosarcoma 3 Paraganglioma 2 Melanoma 2 Kidney Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neoplasms 1 Multiple Myeloma 1

Interventions

Temozolomide 23 Bevacizumab 18 Cyclophosphamide 9 Carboplatin 7 Lomustine 6 Irinotecan 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 5 Filgrastim 5 Radiosurgery 4 Nivolumab 4 Everolimus 4 Etoposide 4 Drug Therapy 4 Busulfan 4 sonidegib 3 pembrolizumab 3 olaparib 3 fludarabine phosphate 3 fludarabine 3 cemiplimab 3 antineoplaston AS 2-1 3 antineoplaston A10 3 Vincristine 3 Thiotepa 3 Sirolimus 3 Melphalan 3 IL13-PE38 3 Antilymphocyte Serum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sunitinib × CNS × Clear all

NCT00535379 2010-08-30

SURGE01-07

Medical University Innsbruck

Phase 2 Unknown

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡